Rigel Pharmaceuticals
RIGL • NASDAQ
Rigel Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Raul R. Rodriguez, with a market cap of $563.8M.
Market Cap$563.8M
Employees147.0
CEORaul R. Rodriguez
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Rigel Pharmaceuticals FAQ
Common questions about Rigel Pharmaceuticals
Rigel Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $63.2M.
Rigel Pharmaceuticals has approximately 147 employees.